Harrow Authorizes Nordic Group Unit to Sell Generic Version of Maxitrol Eye Treatment

MT NewswiresApr 24 12:00 ET

Express News | Nordic Group B.v. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces Launch of Authorized Generic of Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)

ReutersApr 24 10:00 ET

NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)

PR NewswireApr 24 10:00 ET

Harrow Inc (HROW) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Yahoo FinanceApr 21 16:26 ET

Taaleem to Launch Second Harrow International School in Dubai

MT NewswiresApr 13 23:37 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET